VX-522 mRNA therapy
VX21-522-001
Phase 2 small_molecule active
Quick answer
VX-522 mRNA therapy for Cystic Fibrosis is a Phase 2 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Cystic Fibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active